HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430 | -21.7% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $549 | -89.0% | 100 | -95.2% | 0.00% | – |
| Q3 2022 | $5,000 | -58.3% | 2,100 | -36.7% | 0.00% | – |
| Q2 2022 | $12,000 | -42.9% | 3,318 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | -12.5% | 3,318 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | +41.2% | 3,318 | +43.1% | 0.00% | – |
| Q3 2021 | $17,000 | +30.8% | 2,318 | +44.9% | 0.00% | – |
| Q2 2021 | $13,000 | +160.0% | 1,600 | +60.0% | 0.00% | – |
| Q1 2021 | $5,000 | – | 1,000 | +3471.4% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 28 | -96.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 698 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |